Different effects of the BIM deletion polymorphism on treatment of solid tumors by the tyrosine kinase inhibitors (TKI) pazopanib, sunitinib, and lapatinib
Autor: | A. du Bois, Laura R. Parham, L. P. Briley, Mark W. Russo, Colin F. Spraggs, Toby Johnson, Kijoung Song, Chun-Fang Xu, Hiroomi Tada |
---|---|
Rok vydání: | 2015 |
Předmět: |
Indazoles
Indoles Angiogenesis Inhibitors Lapatinib Pazopanib Neoplasms Proto-Oncogene Proteins Sunitinib medicine Humans Pyrroles Prospective Studies Protein Kinase Inhibitors Sulfonamides Polymorphism Genetic Bcl-2-Like Protein 11 business.industry Membrane Proteins Hematology Prognosis Pyrimidines Oncology Quinazolines Cancer research Apoptosis Regulatory Proteins business Tyrosine kinase Gene Deletion Signal Transduction medicine.drug |
Zdroj: | Annals of Oncology. 26:1515-1517 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |